The National Company Law Appellate Tribunal has set aside the plea of a UK-based subsidiary of Punjab National Bank against the NCLT order, approving the sale of Sterling Biotech to US-based food technology startup...
Competition Commission of India clears Kotak-Biocon Biologics deal
Fair trade regulator CCI has cleared Kotak Special Situations Fund’s (KSSF) proposed investment in Biocon Biologics Ltd under the green channel route. In February, KSSF, an arm of Kotak Mahindra Bank, announced a...
Biotech firm Tevogen Bio enters $1.2 billion SPAC deal for US listing
Biotech firm Tevogen Bio will go public in the United States through a blank-check merger that values the combined entity at about $1.2 billion, the companies said on Thursday. The deal with Semper Paratus...
Global funds keen to buy fertility chain Indira IVF
About half a dozen global buyout funds have evinced interest in acquiring India’s largest fertility clinic chain Indira IVF, said people aware of the matter. Blackstone, Baring PE Asia EQT, Warburg Pincus, Bain...
Sherlock Bio to buy UK firm in quest for CRISPR-based handheld diagnostic tests
Privately-held Sherlock Biosciences said it has acquired UK-based Sense Biodetection to speed up the launch of handheld diagnostic tests that use the breakthrough CRISPR gene editing technology. Sherlock raised $80...
Quadria Capital eyes Concord Biotech exit
Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients (API) maker Concord Biotech in the company’s initial public offering (IPO). Rare Enterprises...
EU antitrust regulators likely to block Illumina, Grail deal – sources
EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said. There are doubts whether concessions offered by...
AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion
AstraZeneca agreed to acquire biotechnology firm TeneoTwo Inc in a deal worth up to $1.27 billion, in a move to bolster its roster of therapies to treat blood cancers. At the heart of the deal is the U.S.-based...
Bankruptcy court temporarily stays auction of Gujarat-based Sterling Biotech
The Mumbai bench of the National Company Law Tribunal (NCLT) has directed the liquidator of Sterling Biotech to stay the auctioning process of the company until further orders. The NCLT was hearing a petition filed by...
Rossari to acquire Tristar Intermediates at enterprise value of Rs 120 cr
Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120 crore. The board of the company has approved the acquisition of...
Biocon to acquire 26% stake in Hinduja Renewables Two
Biotechnology major Biocon on Monday said it has inked an agreement for the acquisition of 26 per cent stake on a fully diluted basis in Hinduja Renewables Two Pvt Ltd for Rs 5.91 crore. The indicative time period for...
Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion
Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses. Germany’s Bayer will pay $2 billion upfront and up...
